The FDA should condition any vaccine approval on open trial data December 4, 2020
With only 60 percent of Americans reporting that they’re willing to take a coronavirus vaccine, it’s not enough for the government to…
Read moreFAS experts and affiliates contribute original commentary and opinion pieces in leading media outlets on specific security threats and policy implications.
With only 60 percent of Americans reporting that they’re willing to take a coronavirus vaccine, it’s not enough for the government to…
Read moreThe president and his secretary of state made a startling claim last week: that there is enough evidence to suggest with a high degree of confidence that the Wuhan Institute…
Read moreAs lawmakers in the United States turn their focus to fighting the scourge of COVID-19, they will need to come up to speed quickly on the science behind the virus…
Read moreThe US President’s Council of Advisors on Science and Technology is composed of accomplished individuals from academia and industry who volunteer to help the president. Cabinet secretaries and other federal…
Read moreThe New Voices in Sciences, Engineering, and Medicine (“New Voices”) project was established by the National Academies of Sciences, Engineering, and Medicine to provide diverse perspectives on emerging…
Read moreMy path from bench science to public policy was set in the spring of 2003 when the United States invaded Iraq. At the time, I was a graduate student in…
Read moreAs a senior adviser in the US Senate for the past decade, I find that scientists should be stronger advocates for science. They could learn from farmers, who last December…
Read moreThe following piece reflects the opinions of Dr. Paul J. Sullivan and does not reflect the views of the Federation of American Scientists. I approach this article with some degree of…
Read more